What drives people to Self-Treat with psychedelics? a study investigates

NCT ID NCT06014164

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study explores the experiences of people diagnosed with a psychiatric disorder who have used psychedelic substances on their own to relieve symptoms. Researchers will conduct in-depth interviews with 20 participants to understand their motivations, methods, and perceived effects. The goal is to gather real-world insights that could inform future research and clinical practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
psychedelic substances (self-administered)
What this could lead to
This could help researchers design safer, more effective clinical trials of psychedelic therapies for psychiatric conditions.
What could go wrong
This is a small, observational interview study with only 20 participants, so findings may not apply broadly. It does not test any treatment itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHIATRIC DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital Toulouse

    Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.